Genprex Inc.

Last updated September 27, 2026

Organization details

Legal name
Genprex Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Texas
Headquarters city
Austin
Headquarters state / province
Texas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
GNPX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001595248
EIN
90-0772347

Board of directors

Chief executives

John Rodney Varner · President & CEO
Dates unknown
Ryan M. Confer · President, CEO and CFO
Dates unknown

Director election results

Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$22
2 sales by 1 insider
Date Insider Transaction Shares Price Value
Apr 14, 2026 Brent M. Longnecker Director Open-market sale −8 $1.23 $10
Apr 14, 2026 Brent M. Longnecker Director Open-market sale −10 $1.23 $12
Feb 27, 2026 Berger Mark Stanley Officer (Chief Medical Officer) Shares withheld for tax −7,168 $2.00 $14,336
Feb 27, 2026 Ryan M. Confer Director, Officer (President, CEO and CFO) Shares withheld for tax −9,330 $2.00 $18,660
Dec 22, 2025 Toscano Jose Antonio Moreno Director Grant or award +9,000 — —
Dec 22, 2025 Berger Mark Stanley Officer (Chief Medical Officer) Grant or award +28,500 — —
Dec 22, 2025 Ryan M. Confer Director, Officer (President, CEO and CFO) Grant or award +45,000 — —
Dec 22, 2025 Brent M. Longnecker Director Grant or award +9,000 — —
Dec 22, 2025 William R. Wilson Jr. Director Grant or award +9,000 — —
Jun 30, 2025 Berger Mark Stanley Officer (Chief Medical Officer) Shares withheld for tax −4,500 $0.23 $1,035
Jun 30, 2025 Ryan M. Confer Director, Officer (President, CEO and CFO) Shares withheld for tax −5,775 $0.23 $1,328
Feb 18, 2025 Berger Mark Stanley Officer (Chief Medical Officer) Shares withheld for tax −585 $0.41 $240
Feb 18, 2025 Ryan M. Confer Director, Officer (President, CEO and CFO) Shares withheld for tax −395 $0.41 $162
Dec 5, 2024 Toscano Jose Antonio Moreno Director Grant or award +4,750 — —
Dec 5, 2024 William R. Wilson Jr. Director Grant or award +4,750 — —

Organizations in the same sector, closest in location and size first.

Questions about Genprex Inc.

Who is the CEO of Genprex Inc.?

John Rodney Varner is Genprex Inc.'s President & CEO.

How many directors are on Genprex Inc.'s board?

Genprex Inc.'s board has 5 directors: Brent M. Longnecker, John Rodney Varner, Ryan M. Confer, Toscano Jose Antonio Moreno and William R. Wilson Jr.

Are Genprex Inc. insiders buying or selling shares?

Over the last 12 months, Genprex Inc. insiders made no open-market purchases and sold $22 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="genprex-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.